6.43
-0.04 (-0.62%)
-0.04 (-0.62%)
Upgrade to Real-Time
Regular Market
Low
3.12
High
24.34
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Bio Path Holdings Inc | BPTH | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.04 | -0.62% | 6.43 | 13:45:18 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 6.47 | 6.43 | 6.61 | 6.47 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 6.44 | 6.51 | 0.07 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 192 | 26,864 | $ 6.54 | $ 175,584 | 179,106 | 3.12 - 24.34 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:30:13 | 50 | $ 6.43 | USD |
Bio Path Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 44.75M | 6.96M | 6.93M | $ - | $ - | -2.82 | -2.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 153.00k | - |
Bio Path News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BPTH Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.20 | 7.1999 | 6.15 | 6.68 | 252,194 | 0.23 | 3.71% |
| 1 Month | 5.51 | 7.1999 | 5.41 | 6.15 | 216,315 | 0.92 | 16.7% |
| 3 Months | 6.61 | 10.17 | 5.00 | 7.12 | 591,552 | -0.18 | -2.72% |
| 6 Months | 3.73 | 24.34 | 3.47 | 9.69 | 1,303,617 | 2.70 | 72.39% |
| 1 Year | 5.21 | 24.34 | 3.12 | 8.20 | 934,042 | 1.22 | 23.42% |
| 3 Years | 35.40 | 73.52 | 1.60 | 12.41 | 741,921 | -28.97 | -81.84% |
| 5 Years | 408.00 | 464.00 | 1.60 | 33.54 | 586,260 | -401.57 | -98.42% |
Bio Path Description
| Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. The company's lead drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. Its other drugs are BP1002 and BP1003. |
